新鳳鳴(603225.SH):子公司中磊化纖年產60萬噸功能柔性定製化短纖項目投產
格隆匯11月25日丨新鳳鳴(603225.SH)公佈,公司全資子公司湖州市中磊化纖有限公司(“中磊化纖”)投資建設的年產60萬噸功能柔性定製化短纖項目已達到投產條件。
中磊化纖年產60萬噸功能柔性定製化短纖項目分兩期建設,一期年產30萬噸短纖項目於2021年11月15日進入試運行,經過前期的穩定試運行,目前該項目正式步入投產,項目採用中國崑崙工程有限公司先進的低温、精細化、柔性化的“一頭兩尾”熔體直紡工藝技術流程。
紡絲部分採用多項專用工藝技術,工藝先進、裝備精良,配備最先進的紡絲、卷繞及牽伸設備,以及國內首套全自動打包機和智能倉儲系統。可按客户需求的定製提供高檔高強棉型、水刺、渦流紡、三維中空、彩纖等系列產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.